TGF-β promotes cell death and suppresses lactation during the second stage of mammary involution

Journal of Cellular Physiology

Volumn 219, Issue 1, 2009, Pages 57-68

  Bierie, Brian ^a   Gorska, Agnieszka E ^b   Stover, Daniel G ^a   Moses, Harold L ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; COTRANSPORTER; MESSENGER RNA; MILK PROTEIN; PROTEIN NPT2B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; PROTEIN KINASE B; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SODIUM PHOSPHATE COTRANSPORTER 2B; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; WHEY ACIDIC PROTEINS;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL DEATH; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; INVOLUTION; LACTATION; LACTATION INHIBITION; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL DETECTION; SIGNAL TRANSDUCTION; TRANSGENE; WHEY; ANIMAL; CELL SURVIVAL; GENETICS; LIPID METABOLISM; METABOLISM; NICK END LABELING; PHYSIOLOGY; PREGNANCY; TRANSGENIC MOUSE; UDDER;

MOUSE MAMMARY TUMOR VIRUS;

ANIMALS; CELL DEATH; CELL SURVIVAL; FEMALE; IN SITU NICK-END LABELING; LACTATION; LIPID METABOLISM; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK PROTEINS; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB; STAT3 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 60849083816     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21646     Document Type: Article

References (40)

1. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. 2000. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 97:3444-3449.
2. Bailey JP, Nieport KM, Herbst MP, Srivastava S, Serra RA, Horseman ND. 2004. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol Endocrinol (Baltimore, MD) 18:1171-1184.
3. Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL. 2008. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 68:1809-1819.
4. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ. 1999. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13: 2604-2616.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Chytil A, Magnuson MA, Wright CV, Moses HL. 2002. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 32:73-75.
7. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. 2004. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6:R92-R109.
8. Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ. 2008. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J Biol Chem 283:1293-1307.
9. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S. 2003. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113:301-314.
10. Cordenonsi M, Montagner M, Adorno M, Zacchigna L, Martello G, Mamidi A, Soligo S, Dupont S, Piccolo S. 2007. Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. Science 315:840-843.
11. Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S. 1989. TGF-beta 1-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization. Dev Biol 135:20-30.
12. Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, Piccolo S, Cordenonsi M. 2004. Convergence of p53 and TGF-beta signaling networks. Cancer Lett 213:129-138.
13. Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wakefield L, Barcellos-Hoff MH. 2002. Latent transforming growth factor-beta activation in mammary gland: Regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 160:2081-2093.
14. Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL. 2005. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 65:2296-2302.
15. Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB. 1993. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatalmouse: Aberranthistocompatibilityantigen expressionin the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci USA 90:9944-9948.
16. Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. 1998. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-238.
17. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. 2003. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 163:1539-1549.
18. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU. 2004. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23:6980-6985.
19. Humphreys RC, Bierie B, Zhao L, Raz R, Levy D, Hennighausen L. 2002. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143:3641-3650.
20. Kolek O, Gajkowska B, Godlewski MM, Tomasz M. 2003. Co-localization of apoptosis- regulating proteins in mouse mammary epithelial HC11 cells exposed to TGF-beta1. Eur J Cell Biol 82:303-312.
21. Kordon EC, McKnight RA, Jhappan C, Hennighausen L, Merlino G, Smith GH. 1995. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol 168:47-61.
22. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774.
23. Li W, Qiao W, Chen L, Xu X, Yang X, Li D, Li C, Brodie SG, Meguid MM, Hennighausen L, Deng CX. 2003. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development (Cambridge, England) 130:6143-6153.
24. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE. 2003. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development (Cambridge, England) 130:5257-5268.
25. Mieth M, Boehmer FD, Ball R, Groner B, Grosse R. 1990. Transforming growth factor-beta inhibits lactogenic hormone induction of beta-casein expression in HC11 mouse mammary epithelial cells. Growth Factors 4:9-15.
26. Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, Rosen JM, Robinson GW, Hennighausen L. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155:531-542.
27. Nguyen AV, Pollard JW. 2000. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development (Cambridge, England) 127:3107-3118.
28. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, Doetschman T. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 11:409-414.
29. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. 1991. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development (Cambridge, England) 113:867-878.
30. Robinson SD, Roberts AB, Daniel CW. 1993. TGF beta suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy. J Cell Biol 120:245-251.
31. Shillingford JM, Miyoshi K, Robinson GW, Bierie B, Cao Y, Karin M, Hennighausen L. 2003. Proteotyping of mammary tissue from transgenic and gene knockout mice with immunohistochemical markers: A tool to define developmental lesions. J Histochem Cytochem 51:555-565.
32. Silberstein GB, Daniel CW. 1987. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 237:291-293.
33. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
34. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. 2004. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6:R75-R91.
35. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. 1993. Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol 120:253-260.
36. Sudlow AW, Wilde CJ, Burgoyne RD. 1994. Transforming growth factor-beta 1 inhibits casein secretion from differentiating mammary-gland explants but not from lactating mammary cells. Biochem J 304:333-336.
37. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang AM, Sterneck E. 2005. C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development (Cambridge, England) 132:4675-4685.
38. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. 1997. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25:4323-4330.
39. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. 2001. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10:545-553.
40. Yang YA, Tang B, Robinson G, Hennighausen L, Brodie SG, Deng CX, Wakefield LM. 2002. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor- beta. Cell Growth Differ 13:123-130.